Department of Gastroenterology, Kanazawa University Hospital, 13-1, Takara-Machi, Kanazawa City, Ishikawa Prefecture, 920-8641, Japan.
Innovative Clinical Research Center, Kanazawa University, 13-1, Takara-Machi, Kanazawa City, Ishikawa Prefecture, 920-8641, Japan.
Sci Rep. 2022 Dec 6;12(1):21100. doi: 10.1038/s41598-022-25186-2.
This study aimed to evaluate the efficacy of a novel fully covered self-expandable metal stent (SEMS) with dumbbell-shaped flare ends for the palliation of distal biliary obstruction (DBO) due to unresectable pancreatic cancer (UPC). Patients with DBO due to UPC who received the novel HILZO fully covered stent (HFS), the WALLFLEX partially covered stent (WPS) or fully covered stent (WFS) were analyzed. The incidence of recurrent biliary obstruction (RBO), time to RBO (TRBO), and the incidence of complications were compared among the three SEMS groups. Eighty-four patients (HFS, n = 36; WPS, n = 20; WFS, n = 28) were included. The incidence of RBO was low in the HFS group (versus the WPS and WFS group, p = 0.033 and 0.023, respectively). TRBO in the HFS group was longer than that in the WFS group (p = 0.049). Placement of the HFS was an independent factor for long TRBO in multivariable analysis (p = 0.040). The incidence of pancreatitis and cholecystitis in the HFS group was low (one for each). It is recommended to use the HFS for the palliation of DBO due to UPC from the viewpoint of the low incidence of RBO and complications.
本研究旨在评估一种新型哑铃形喇叭口全覆膜自膨式金属支架(SEMS)治疗不可切除胰腺癌(UPC)所致远端胆道梗阻(DBO)的疗效。对接受新型 HILZO 全覆膜支架(HFS)、WALLFLEX 部分覆膜支架(WPS)和全覆膜支架(WFS)治疗的 UPC 所致 DBO 患者进行分析。比较三组 SEMS 患者复发性胆道梗阻(RBO)的发生率、RBO 时间(TRBO)以及并发症的发生率。共纳入 84 例患者(HFS 组 36 例,WPS 组 20 例,WFS 组 28 例)。HFS 组 RBO 发生率较低(与 WPS 组和 WFS 组相比,p=0.033 和 0.023)。HFS 组 TRBO 长于 WFS 组(p=0.049)。多变量分析显示,HFS 的放置是 TRBO 较长的独立因素(p=0.040)。HFS 组胰腺炎和胆囊炎的发生率较低(各 1 例)。从 RBO 发生率低和并发症少的角度来看,建议使用 HFS 来缓解 UPC 引起的 DBO。